Related Experiment Video
Updated: Aug 15, 2026

10:52
Preparation of Mouse Pituitary Immunogen for the Induction of Experimental Autoimmune Hypophysitis
Published on: December 17, 2010
Resetting immunometabolic set points in autoimmune disease
Xiao Yu1,2, Yidan Zhang3, Anquan Shang4
1Department of Otolaryngology-Head and Neck Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Journal of Translational Autoimmunity
|August 14, 2026
Summary
Chronic autoimmune diseases may persist due to stable "immunometabolic set points" influencing immune cells and tissues. Understanding these states is key to preventing relapse after treatment withdrawal.
Area of Science:
- Immunology
- Metabolic Biology
- Autoimmune Disease Research
Background:
- Autoimmune diseases often persist despite inflammation suppression, with frequent relapses upon treatment reduction.
- This suggests stable biological states, beyond active immune stimulation, may maintain disease activity.
Purpose of the Study:
- To propose an integrative framework of "immunometabolic set points" for chronic autoimmune diseases.
- To examine interactions between immune cell metabolism, tissue microenvironments, and metabolite signaling in disease persistence.
Main Methods:
- Review of experimental studies on cellular metabolism, nutrient conditions, mitochondrial stress, and metabolite signaling in immune regulation.
- Conceptual framework development integrating these factors into a disease-maintaining state.
Main Results:
- Experimental evidence supports roles for cellular metabolism, tissue niches, and specific metabolites (lactate, succinate, itaconate) in immune function.
- The integration of these factors into a unified, disease-maintaining state requires further establishment.
Conclusions:
- Immunometabolic set points offer a novel framework to understand chronic autoimmune disease persistence and relapse.
- Future research using advanced omics and metabolic analyses can test this framework and inform therapeutic strategies for durable remission.